The causal relationship between epigenetic aging and osteoporosis: a bi-directional Mendelian randomization study

Abstract

Aim: Osteoporosis (OP) is the most common of the musculoskeletal disorders, with decreased bone mineral density (BMD) being the main manifestation and exacerbating fracture susceptibility. OP was once thought to be an inevitable consequence of aging. We conducted a bi-directional Mendelian randomization (MR) for epigenetic age acceleration (EAA) and osteoporosis to accurately assess the interaction between aging and osteoporosis.

Methods: This study collected data from genome-wide association studies of EAA and OP and assessed significant genetic variables. Bi-directional MR analyses were performed using random-effects inverse-variance weighting as the primary method, and the interaction of epigenetic age acceleration with OP was assessed using other MRI methods and multiple sensitivity analyses.

Results: Inverse-variance weighted (IVW) results suggest that GrimAge acceleration accelerates bone loss in total body bone mineral density [odds ratio (OR) = 1.035, 95% confidence interval (95%CI) = (1.003, 1.069), P = 0.033]. The effect of BMD on EAA was investigated, and a causal relationship was found between forearm bone mineral density and GrimAge acceleration [OR = 0.682, (95%CI) = (0.508, 0.916), P = 0.011]. There was a causal relationship between femoral neck bone mineral density and PhenoAge acceleration [OR = 1.452, (95%CI) = (1.007, 2.096), P = 0.046].

Conclusions: Epigenetic age acceleration was bi-directionally causally associated with osteoporosis. GrimAge acceleration increased the risk of decreased total body bone mineral density. Forearm bone mineral density accelerated GrimAge and femoral neck bone mineral density accelerated PhenoAge acceleration.

Keywords

Osteoporosis / epigenetic age acceleration / Mendelian randomization

References

[1] SongS,YangY.Advances in pathogenesis and therapeutic strategies for osteoporosis.Pharmacol Ther2022;237:108168

[2] BlackDM,AdamsAL.Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates.Reply.N Engl J Med2020;383:2188-90

[3] WangJ,ShengN.associations of the geriatric nutritional risk index with femur bone mineral density and osteoporosis in american postmenopausal women: data from the national health and nutrition examination survey.Front Nutr2022;9:860693 PMCID:PMC9152150

[4] KhoslaS.Osteoporosis treatment: recent developments and ongoing challenges.Lancet Diabetes Endocrinol2017;5:898-907 PMCID:PMC5798872

[5] LiuJ,CooperC.State of the art in osteoporosis risk assessment and treatment.J Endocrinol Invest2019;42:1149-64 PMCID:PMC6751157

[6] AyersC,LazurB,KwonA.Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American college of physicians.Ann Intern Med2023;176:182-95

[7] WuYL,LiCC.Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study.Signal Transduct Target Ther2023;8:98 PMCID:PMC9981733

[8] ChenYS,KuoCW.Epigenetic regulation of skeletal tissue integrity and osteoporosis development.Int J Mol Sci2020;21:4923 PMCID:PMC7404082

[9] YuW,ZhangJ.The effects of epigenetic modifications on bone remodeling in age-related osteoporosis.Connect Tissue Res2023;64:105-16

[10] DuanR,SunY.Epigenetic clock: a promising biomarker and practical tool in aging.Ageing Res Rev2022;81:101743

[11] JylhäväJ,HäggS.Biological age predictors.EBioMedicine2017;21:29-36 PMCID:PMC5514388

[12] MarioniRE,McRaeAF.DNA methylation age of blood predicts all-cause mortality in later life.Genome Biol2015;16:25 PMCID:PMC4350614

[13] HorvathS.DNA methylation age of human tissues and cell types.Genome Biol2013;14:R115

[14] HannumG,ZhaoL.Genome-wide methylation profiles reveal quantitative views of human aging rates.Mol Cell2013;49:359-67 PMCID:PMC3780611

[15] LevineME,QuachA.An epigenetic biomarker of aging for lifespan and healthspan.Aging (Albany NY)2018;10:573-91 PMCID:PMC5940111

[16] LuAT,WilsonJG.DNA methylation GrimAge strongly predicts lifespan and healthspan.Aging (Albany NY)2019;11:303-27 PMCID:PMC6366976

[17] HillaryRF,McCartneyDL.Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden.Clin Epigenetics2020;12:115 PMCID:PMC7394682

[18] HuangM,LiuL.m6A methylation regulates osteoblastic differentiation and bone remodeling.Front Cell Dev Biol2021;9:783322 PMCID:PMC8724434

[19] Fernandez-RebolloE,SeefriedL.Primary osteoporosis is not reflected by disease-specific dna methylation or accelerated epigenetic age in blood.J Bone Miner Res2018;33:356-61

[20] Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies.Hum Mol Genet2014;23:R89-98 PMCID:PMC4170722

[21] LawlorDA,SterneJA,DaveySmith G.Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.Stat Med2008;27:1133-63

[22] XuW,ShiY,ShiB.Causal association of epigenetic aging and COVID-19 severity and susceptibility: A bidirectional Mendelian randomization study.Front Med (Lausanne)2022;9:989950 PMCID:PMC9538153

[23] ZhangF,ZhangJ.Causality between heart failure and epigenetic age: a bidirectional Mendelian randomization study.ESC Heart Fail2023;10:pp.2903-13 PMCID:PMC10567637

[24] PanY,HuangZ.Effects of epigenetic age acceleration on kidney function: a Mendelian randomization study.Clin Epigenetics2023;15:61 PMCID:PMC10082992

[25] LiuC,XiaY,XiaoT.osteoporosis and sarcopenia-related traits: a bi-directional Mendelian randomization study.Front Endocrinol (Lausanne)2022;13:975647 PMCID:PMC9515352

[26] TangF,ZhaoH,DongX.Mendelian randomization analysis does not reveal a causal influence of mental diseases on osteoporosis.Front Endocrinol (Lausanne)2023;14:1125427 PMCID:PMC10157183

[27] LinL,YangM,HouW.Causal relationship between osteoporosis and osteoarthritis: a two-sample Mendelian randomized study.Front Endocrinol (Lausanne)2022;13:1011246 PMCID:PMC9633945

[28] HartwigFP,HemaniG.Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.Int J Epidemiol2016;45:1717-26 PMCID:PMC5722032

[29] BowdenJ,HaycockPC.Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.Genet Epidemiol2016;40:304-14 PMCID:PMC4849733

[30] YuM,LuebeckGE.Epigenetic aging: more than just a clock when it comes to cancer.Cancer Res2020;80:367-74 PMCID:PMC7002254

[31] SimpsonDJ.Epigenetic age prediction.Aging Cell2021;20:e13452 PMCID:PMC8441394

[32] JiangZ,HuJ,ShenY.Integration analysis of epigenetic-related m⁶A-SNPs associated with atrial fibrillation.CVIA2023;8

[33] FuggleNR,HarveyNC.A review of epigenetics and its association with ageing of muscle and bone.Maturitas2022;165:12-7

[34] ConteM,ChiarielloA,FranceschiC.GDF15, an emerging key player in human aging.Ageing Res Rev2022;75:101569

[35] McCroryC,HernandezB.GrimAge outperforms other epigenetic clocks in the prediction of age-related clinical phenotypes and all-cause mortality.J Gerontol A Biol Sci Med Sci2021;76:741-9 PMCID:PMC8087266

[36] ReppeS,GautvikVT.Eight genes are highly associated with BMD variation in postmenopausal Caucasian women.Bone2010;46:604-12

[37] CheishviliD,MahmoodN.Identification of an epigenetic signature of osteoporosis in blood DNA of postmenopausal women.J Bone Miner Res2018;33:1980-9

[38] DelReal A,FernándezAF.Differential analysis of genome-wide methylation and gene expression in mesenchymal stem cells of patients with fractures and osteoarthritis.Epigenetics2017;12:113-22 PMCID:PMC5330439

[39] EthansKD.Hip fracture in the elderly. An interdisciplinary team approach to rehabilitation.Postgrad Med1998;103:167-70

[40] LawsonA,BuchbinderR.Combined Randomised and Observational Study of Surgery for Fractures in the Distal Radius in the Elderly (CROSSFIRE) Study GroupSurgical plating vs closed reduction for fractures in the distal radius in older patients: a randomized clinical trial.JAMA Surg2021;156:229-37 PMCID:PMC7807386